XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Operations and Other Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Income Statement [Abstract]        
License and collaboration revenue $ 15,799 $ 763 $ 40,883 $ 775
Revenue, Product and Service [Extensible List] us-gaap:LicenseMember us-gaap:LicenseMember us-gaap:LicenseMember us-gaap:LicenseMember
Operating expenses:        
Research and development $ 85,287 $ 54,623 $ 225,253 $ 290,306
General and administrative 21,815 15,774 65,124 39,450
Total operating expenses 107,102 70,397 290,377 329,756
Loss from operations (91,303) (69,634) (249,494) (328,981)
Other income (expense):        
Change in fair value of derivative liabilities (4,900) 35,800 20,900 (8,400)
Change in fair value of non-controlling equity investments 10,431 (4,892) (1,378) 21,960
Change in fair value of contingent consideration liabilities (875) 10,599 (543) 9,553
Interest and other income (expense), net 4,982 9 7,686 (63)
Total other income (expense) 9,638 41,516 26,665 23,050
Net loss before income taxes (81,665) (28,118) (222,829) (305,931)
Provision for income taxes (2,410) 0 (2,410) 0
Loss from equity method investment (25,500)   (25,500)  
Net loss (109,575) (28,118) (250,739) (305,931)
Unrealized gain (loss) on marketable securities (484) (12) (4,624) 28
Comprehensive loss $ (110,059) $ (28,130) $ (255,363) $ (305,903)
Net loss per common share, basic $ (1.56) $ (0.42) $ (3.59) $ (4.86)
Net loss per common share, diluted $ (1.56) $ (0.42) $ (3.59) $ (4.86)
Weighted-average common shares outstanding, basic 70,343,196 66,377,611 69,758,434 62,960,219
Weighted-average common shares outstanding, diluted 70,343,196 66,377,611 69,758,434 62,960,219